封面
市場調查報告書
商品編碼
1624418

全球 qPCR 試劑市場規模(按最終用戶、應用、包裝類型、檢測方法、地區、範圍和預測)

Global qPCR Reagents Market Size By End-User, By Application, By Packaging Type, By Detection Method, By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

qPCR 試劑市場規模及預測

2023 年 qPCR 試劑市場規模價值為 23.9135 億美元,預計到 2031 年將達到 47.5095 億美元,2024-2031 年預測期內的複合年增長率為 8.96%。

qPCR 試劑的全球市場驅動因子

qPCR 試劑市場的市場推動因素可能受到多種因素的影響。

技術開發:

提高 qPCR 檢測的準確性、靈敏度和速度正在推動更好的 qPCR 技術的開發,包括更好的試劑、設備和軟體。

擴大研究用途:

隨著 qPCR 在轉錄組學、藥物發現、基因組學和分子診斷等許多研究領域的應用不斷擴大,市場也不斷擴大。病毒量定量、生物標記分析、突變檢測和基因表現分析都是 qPCR 的常見應用。

對個人化醫療的興趣日益濃厚

qPCR 技術在分子診斷和個人化醫療領域變得越來越重要,因為它可用於識別基因突變、疾病標記和預測治療結果。這促使對 qPCR 試劑的需求增加。

增加傳染病檢測:

COVID-19 疫情凸顯了 qPCR 等快速且準確的傳染病診斷方法的重要性。因此,對用於追蹤和病毒鑑定的 qPCR 試劑的需求日益增加。

製藥和生物技術市場成長:

隨著生物技術和製藥行業的增長以及研發活動投入的增加,藥物發現、開發和驗證程序中對 qPCR 試劑的需求正在增長。

自動化與高通量系統:

隨著自動化 qPCR 系統和高通量平台在實驗室和研究中心變得越來越普遍,對 qPCR 試劑的需求也日益增加。

政府措施與資金:

政府對分子生物學、遺傳學和診斷學研究計畫的支持計畫、補助金和貸款透過鼓勵使用 qPCR 技術和試劑促進了市場的成長。

由於癌症、心血管疾病和傳染病等慢性疾病的發生率不斷增加,臨床診斷對 qPCR 試劑的需求日益增加。這些疾病需要 qPCR 等靈敏、準確的診斷技術。

限制全球 qPCR 試劑市場的因素

有幾個因素可能會對 qPCR 試劑市場造成限制和課題。

成本高:

qPCR 試劑(包括酵素、引子、探針和其他成分)的成本相對較高,這可能會限制它們在某些研究或診斷環境中的採用。

複雜性與專業性:

qPCR 技術需要專門的設備和技術專長才能準確執行。對於沒有必要資源的小型實驗室或研究人員來說,這可能是一個障礙。

與替代技術的衝突:

其他分子生物學技術,例如數位 PCR(dPCR)和下一代定序(NGS),為核酸定量提供了替代方法,並與 qPCR 試劑競爭。

敏感度有限:

儘管 qPCR 靈敏度高,但它可能無法像數位 PCR 等新技術那樣有效地檢測低水平基因表現變化或罕見突變。

樣本完整性和品質控制:

在整個 qPCR 過程中維持樣本完整性和確保品質控制可能具有課題性,從而促使潛在的變異性和可靠性問題。

監理課題:

遵守監管要求,尤其是在診斷應用中,可能會給 qPCR 試劑製造商和用戶帶來課題,從而影響市場成長。

供應鏈中斷:

供應鏈中斷(例如原料短缺或製造課題)可能會影響 qPCR 試劑的可用性和定價。

多重化能力限制:

儘管可以進行多重 qPCR 檢測,但可同時檢測的目標數量受到限制,這可能會影響 qPCR 應用的可擴展性。

目錄

第 1 章 全球 QPCR 試劑市場簡介

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章:經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第4章 全球 qPCR 試劑市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第 5 章 全球 QPCR 試劑市場(依最終用戶劃分)

  • 概述
  • 製藥和生技公司
  • 法醫科學實驗室
  • 研究實驗室和學術機構
  • 醫院和診斷中心
  • 臨床研究機構
第6章 全球 qPCR 試劑市場(依應用)
  • 概述
  • 診斷應用
  • 法醫應用
  • 研究用途
第 7 章 全球 qPCR 試劑市場(依包裝類型)
  • 概述
  • qPCR 核心試劑盒 qPCR 預混液

第8章全球 qPCR 試劑市場(依檢測方法)

  • 概述 基於染料的 qPCR 試劑
  • 基於探針和引子的 qPCR 試劑

第 9 章 全球 QPCR 試劑市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲
第 10 章全球 qPCR 試劑市場競爭格局
  • 概述
  • 各公司的市場排名
  • 主要發展策略

第 11 章 公司簡介

  • Qiagen N.V
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Takara Bio. Inc
  • Thermo Fischer Scientific Inc.
  • Affymetrix Inc.
  • Promega Corporation
  • Quanta Biosciences
  • F.Hoffman-La-Roche-Ltd

第 12 章 重大進展

  • 產品發佈/開發
  • 合併和收購
  • 業務擴展
  • 夥伴關係和合作關係

第 13 章附錄

  • 相關研究
簡介目錄
Product Code: 24258

qPCR Reagents Market Size And Forecast

qPCR Reagents Market size was valued at USD 2391.35 Million in 2023 and is projected to reach USD 4750.95 Million by 2031, growing at a CAGR of 8.96% during the forecast period 2024-2031. Global qPCR Reagents Market Drivers The market drivers for the qPCR Reagents Market can be influenced by various factors. These may include: Technological Developments:

By increasing the precision, sensitivity, and speed of qPCR tests, ongoing developments in qPCR technology, such as better reagents, devices, and software, fuel market expansion.

Growing Use in Research:

The market is growing as a result of the growing use of qPCR in a number of research fields, including transcriptomics, drug discovery, genomics, and molecular diagnostics. Viral load quantification, biomarker analysis, mutation detection, and gene expression analysis are all common uses for qPCR.

Growing Interest in Personalised Medicine:

As qPCR technology is used to identify genetic variations, disease markers, and treatment response prediction, it is becoming more and more important in the field of molecular diagnostics and personalised medicine. This has led to an increase in the demand for qPCR reagents.

Increase in Testing for Infectious Diseases:

The COVID-19 pandemic brought to light the significance of quick and precise diagnostic methods, such as qPCR, for infectious diseases. As a result, there is now a greater need for qPCR reagents for tracking and virus identification.

Growing Markets for Pharmaceuticals and Biotechnology:

The need for qPCR reagents for drug discovery, development, and validation procedures is driven by the growth of the biotechnology and pharmaceutical sectors as well as higher investment in research and development activities.

Automation and High-Throughput Systems:

As automated qPCR systems and high-throughput platforms become more common in labs and research centres, there is a greater need for qPCR reagents since these systems need specific reagents to function well.

Government Initiatives and financing:

By promoting the use of qPCR technology and reagents, supportive government initiatives, grants, and financing for research projects in molecular biology, genetics, and diagnostics contribute to market growth.

The need for qPCR reagents in clinical diagnostics is being driven by the increasing frequency of chronic diseases, which include cancer, cardiovascular disorders, and infectious diseases. These diseases require sensitive and accurate diagnostic techniques, like qPCR.

Global qPCR Reagents Market Restraints

Several factors can act as restraints or challenges for the qPCR Reagents Market. These may include:

High Cost:

The cost of qPCR reagents, including enzymes, primers, probes, and other components, can be relatively high, which may limit their adoption in certain research or diagnostic settings.

Complexity and Technical Expertise:

qPCR techniques require specialized equipment and technical expertise to perform accurately. This can be a barrier for small laboratories or researchers without the necessary resources.

Competition from Alternative Technologies:

Other molecular biology techniques like digital PCR (dPCR) and next-generation sequencing (NGS) offer alternative methods for nucleic acid quantification, posing competition to qPCR reagents.

Limited Sensitivity:

While qPCR is highly sensitive, it may not detect low-level gene expression changes or rare mutations as effectively as newer technologies like digital PCR.

Sample Integrity and Quality Control:

Maintaining sample integrity and ensuring quality control throughout the qPCR process can be challenging, leading to potential variability and reliability issues.

Regulatory Challenges:

Compliance with regulatory requirements, especially in diagnostic applications, can pose challenges for qPCR reagent manufacturers and users, impacting market growth.

Supply Chain Disruptions:

Disruptions in the supply chain, such as shortages of raw materials or manufacturing challenges, can affect the availability and pricing of qPCR reagents.

Limited Multiplexing Capacity:

Although multiplex qPCR assays are possible, they may have limitations in terms of the number of targets that can be simultaneously detected, affecting the scalability of qPCR applications.

Global qPCR Reagents Market: Segmentation Analysis

The Global qPCR Reagents Market is Segmented on the basis of End-User, Application, Packaging Type, Detection Method, and Geography.

qPCR Reagents Market, By End-User

  • Pharmaceutical and Biotechnology Companies
  • Forensic Laboratories
  • Research Laboratories and Academic Institutes
  • Hospitals and Diagnostic Centres
  • Clinical Research Organization

Based on End-User, The market is segmented into Pharmaceutical and Biotechnology Companies, Forensic Laboratories, Research Laboratories and Academic Institutes, Hospitals and Diagnostic Centres, and Clinical Research organizations. The Hospitals and Diagnostic have the largest growth of the Global qPCR Reagents Market due to the dominant market position of hospitals and diagnostic centers can be credited to the advancement of the healthcare system for effective diagnosis and treatment, the rising proportion of qPCR reagents initiated for diagnostic applications, and the benefits provided by qPCR in the diagnosis of diseases.

qPCR Reagents Market, By Application

  • Diagnostic Application
  • Forensic Application
  • Research Application

Based on Application, The market is segmented into Diagnostic Application, Forensic Application, and Research Application. The research application has the highest growth of the Global qPCR Reagents Market because of their increasing applications in fields including stem cell research, microbiology, and agricultural production as compared to other segments of the market during the forecasted period.

qPCR Reagents Market, By Packaging Type

  • qPCR Core Kits
  • qPCR Master Mixes

Based on Packaging Type, The market is segmented into qPCR Core Kits and qPCR Master Mixes. The qPCR Core Kits has the largest growth of the Global qPCR Reagents Market due to its large market share is driven by factors such as low core kit prices, end-user flexibility, rising private-public funding for life science research, and growing market provision of qPCR core kits in countries involved throughout the projected period.

qPCR Reagents Market, By Detection Method

  • Dye-Based qPCR Reagents
  • Probes and Primer-Based qPCR Reagents

Based on Detection Method, The market is segmented into Dye-Based qPCR Reagents and Probes and Primer-Based qPCR Reagents. The Dye-Based qPCR Reagent has the largest growth of the Global qPCR Reagents Market. Dye-based diagnostic qualitative PCR is being used rapidly to identify nucleic acids that are important in the diagnosis of infectious diseases, cancer, and genetic problems, among many other things. Furthermore, Cancer Research UK predicts that the number of cancer patients is expected to rise significantly.

qPCR Reagents Market, By Geography

  • North America
  • Europ
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific is projected to be the highest growing market over the forecasted period due to the high penetration of global life sciences companies in this region, increasing government focus on raising awareness about gene-based diagnostics and therapeutics, rising public and private incentives for the implementation of novel qPCR technology solutions, and progress of cancer research in Japan.

Key Players

  • The major players in the qPCR Reagents Market are:
  • Thermo Fischer Scientific Inc.
  • Agilent Technologies
  • Affymetrix Inc.
  • Takara Bio. Inc
  • Qiagen N.V
  • Bio-Rad Laboratories
  • Promega Corporation

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL QPCR REAGENTS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL QPCR REAGENTS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL QPCR REAGENTS MARKET, BY END-USER

  • 5.1 Overview
  • 5.2 Pharmaceutical and Biotechnology Companies
  • 5.3 Forensic Laboratories
  • 5.4 Research Laboratories and Academic Institutes
  • 5.5 Hospitals and Diagnostic Centres
  • 5.6 Clinical Research Organization

6 GLOBAL QPCR REAGENTS MARKET, BY APPLICATIONS

  • 6.1 Overview
  • 6.2 Diagnostic Application
  • 6.3 Forensic Application
  • 6.4 Research Application

7 GLOBAL QPCR REAGENTS MARKET, BY PACKAGING TYPE

  • 7.1 Overview
  • 7.2 qPCR Core Kits
  • 7.3 qPCR Master Mixes

8 GLOBAL QPCR REAGENTS MARKET, BY DETECTION METHOD

  • 8.1 Overview
  • 8.2 Dye-Based qPCR Reagents
  • 8.3 Probes and Primer-Based qPCR Reagents

9 GLOBAL QPCR REAGENTS MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.3 Canada
    • 9.2.4 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East and Africa

10 GLOBAL QPCR REAGENTS MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 Qiagen N.V
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 Bio-Rad Laboratories
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Agilent Technologies
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 Takara Bio. Inc
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Thermo Fischer Scientific Inc.
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Affymetrix Inc.
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 Promega Corporation
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments
  • 11.8 Quanta Biosciences
    • 11.8.1 Overview
    • 11.8.2 Financial Performance
    • 11.8.3 Product Outlook
    • 11.8.4 Key Developments
  • 11.9 F.Hoffman-La-Roche-Ltd
    • 11.9.1 Overview
    • 11.9.2 Financial Performance
    • 11.9.3 Product Outlook
    • 11.9.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research